motavizumab

MedImmune sues Abbott over drug development deal
Bizjournals.com
Mon, 08/22/11 - 06:02 pm
Abbott Laboratories
MedImmune
motavizumab
Deals to Be Done After AstraZeneca Setback
WSJ Online
Thu, 12/23/10 - 08:26 am
AstraZeneca
RSV
Cubist Pharmaceuticals
NanoBio
MicroDose Therapeutx
Novavax
Synagis
motavizumab
Alnylam
AstraZeneca Halts Drug, Takes Big Charge
TheStreet.com
Tue, 12/21/10 - 10:07 am
AstraZeneca
motavizumab
RSV
Red Signal for AstraZeneca Drug
Yahoo/Zacks.com
Mon, 09/6/10 - 10:01 am
AstraZeneca
MedImmune
RSV
motavizumab
AstraZeneca considering options after failing to win US approval for respiratory drug
Yahoo/AP
Tue, 08/31/10 - 07:42 am
AstraZeneca
FDA
motavizumab
FDA Resets Motavizumab Decision to Aug. 27
TopWireNews
Sat, 06/26/10 - 10:50 am
motavizumab
RSV
MedImmune
AstraZeneca
AstraZeneca: FDA changes motavizumab review date
Marketwatch
Fri, 06/25/10 - 10:14 am
FDA
AstraZeneca
motavizumab
RSV
monoclonal antibodies
FDA Committee Votes to Reject AstraZeneca RSV Drug: Biotech's Latest Mishaps
Seeking Alpha
Sun, 06/6/10 - 11:03 am
RSV
AstraZeneca
MedImmune
motavizumab
Axanum
FDA panel rejects AZ's new RSV drug in key setback
Fierce Biotech
Thu, 06/3/10 - 10:07 am
RSV
motavizumab
MedImmune
FDA
AstraZeneca
Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
Yahoo/PR NewsWire
Sat, 01/30/10 - 11:11 am
MedImmune
motavizumab
RSV